Gress TM - Search Results

1

CUX1-Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors.

Krug S, Weissbach J, Blank A, Perren A, Haybaeck J, Fendrich V, Rinke A, Gress TM, Rosendahl J, Michl P. Krug S, et al. Among authors: gress tm. Cancers (Basel). 2020 Jul 19;12(7):1957. doi: 10.3390/cancers12071957. Cancers (Basel). 2020. PMID: 32707646 Free PMC article.

2

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.

Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM. Weber CK, et al. Among authors: gress tm. Gastroenterology. 2001 Sep;121(3):657-67. doi: 10.1053/gast.2001.27222. Gastroenterology. 2001. PMID: 11522750

3

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

Michl P, Buchholz M, Rolke M, Kunsch S, Löhr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM. Michl P, et al. Among authors: gress tm. Gastroenterology. 2001 Sep;121(3):678-84. doi: 10.1053/gast.2001.27124. Gastroenterology. 2001. PMID: 11522752

4

Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.

Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, Leder G, Iwamura T, Adler G, Gress TM. Michl P, et al. Among authors: gress tm. Cancer Res. 2003 Oct 1;63(19):6265-71. Cancer Res. 2003. PMID: 14559813

5

Bacteria and bacterial toxins as therapeutic agents for solid tumors.

Michl P, Gress TM. Michl P, et al. Among authors: gress tm. Curr Cancer Drug Targets. 2004 Dec;4(8):689-702. doi: 10.2174/1568009043332727. Curr Cancer Drug Targets. 2004. PMID: 15578923 Review.

6

Evidence-based diagnosis and staging of pancreatic cancer.

Michl P, Pauls S, Gress TM. Michl P, et al. Among authors: gress tm. Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):227-51. doi: 10.1016/j.bpg.2005.10.005. Best Pract Res Clin Gastroenterol. 2006. PMID: 16549326 Review.

7

Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.

Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V. Buchholz M, et al. Among authors: gress tm. EMBO J. 2006 Aug 9;25(15):3714-24. doi: 10.1038/sj.emboj.7601246. Epub 2006 Jul 27. EMBO J. 2006. PMID: 16874304 Free PMC article.

8

CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.

Aleksic T, Bechtel M, Krndija D, von Wichert G, Knobel B, Giehl K, Gress TM, Michl P. Aleksic T, et al. Among authors: gress tm. Oncogene. 2007 Aug 30;26(40):5939-49. doi: 10.1038/sj.onc.1210398. Epub 2007 Mar 19. Oncogene. 2007. PMID: 17369846

9

Multifocal early gastric cancer in a patient with autoimmune atrophic gastritis and iron deficiency anaemia.

Neesse A, Michl P, Barth P, Vieth M, Langer P, Ellenrieder V, Gress TM. Neesse A, et al. Among authors: gress tm. Z Gastroenterol. 2009 Feb;47(2):223-7. doi: 10.1055/s-2008-1027558. Epub 2009 Feb 5. Z Gastroenterol. 2009. PMID: 19197826

10

Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study.

Kalinowski M, Dressler M, König A, El-Sheik M, Rinke A, Höffken H, Gress TM, Arnold R, Klose KJ, Wagner HJ. Kalinowski M, et al. Among authors: gress tm. Digestion. 2009;79(3):137-42. doi: 10.1159/000209849. Epub 2009 Mar 23. Digestion. 2009. PMID: 19307736 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters